Quality of life changes in patients undergoing treatment for hepatocellular carcinoma

doi:10.1007/s11136-015-0985-8

淡江大學機構典藏 > 理學院 > 數學學系暨研究所 > 期刊論文 > Item 987654321/122692

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/122692

题名:	Quality of life changes in patients undergoing treatment for hepatocellular carcinoma
作者:	Chie, Wei-Chu;Yu, Fang;Li, Mengqian;Baccaglini, Lorena;Blazeby, Jane M;Hsiao, Chin-Fu;Chiu, Herng-Chia;Poon, Ronnie T;Mikoshiba, Naoko;Gillian, Al-Kadhimi;Heaton, Nigel;Calara, Jozer;Collins, Peter;Caddick, Katharine;Costantini, Anna;Vilgrain, Valerie;Chiang, Chieh
关键词:	Quality of life;Asian;Treatment;Hepatocellular;Carcinoma
日期:	2015-05-06
上传时间:	2022-05-09 12:10:22 (UTC+8)
摘要:	Purpose Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. One of the primary treatment goals for incurable advanced cases is to prolong quality of life (QoL). Thus, to determine which HCC therapies may be linked to a more favorable QoL, we assessed the association between QoL changes and different treatments in HCC patients. Methods We analyzed a non-randomized multicenter longitudinal study, which included 171 patients treated with surgery (n = 53), ablation (n = 53) or embolization (n = 65) from seven centers: four Asian and three European sites. All participants completed the EORTC QLQ-C30 and QLQ-HCC18 questionnaires before and after treatment. Propensity scores were calculated and used in addition to race for adjustment in the logistic regression model to account for the confounding effects of patient characteristics including age, gender, race, employment, living with family, at least one comorbid condition, years since diagnosis, prior treatment history, BCLC stage, Child–Pugh grade, cirrhosis, bilirubin levels and QoL score before treatment. Results After adjustment for confounders, patients tended to have higher odds of QoL deterioration when treated with ablation versus embolization (dyspnea: p = 0.019; appetite loss: p = 0.018; body image: p = 0.035) or ablation versus surgery (dyspnea: p = 0.099; appetite loss: p = 0.100; body image: p = 0.038). Conclusions There were significant differences in QoL deterioration across different treatment groups. This information may assist patients and providers when selecting patient-centered treatment approaches for HCC.
關聯:	Quality of Life Research 24(10), 2499-2506
DOI:	10.1007/s11136-015-0985-8
显示于类别:	[數學學系暨研究所] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	29	检视/开启

在機構典藏中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....